Extranodal NK/T Cell Lymphoma Clinical Trial
Official title:
Retrospective Analysis of Skin/Soft Tissue Primary NK/T Cell Lymphoma
| NCT number | NCT01341119 |
| Other study ID # | 2010-11-047 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | April 21, 2011 |
| Last updated | August 6, 2012 |
| Start date | November 2010 |
| Verified date | August 2012 |
| Source | Samsung Medical Center |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | South Korea: Institutional Review Board |
| Study type | Observational |
To study clinical features, prognostic factors and treatment outcome and to develop a possible prognostic index in skin/soft tissue primary NK/T cell lymphoma patients.
| Status | Completed |
| Enrollment | 40 |
| Est. completion date | |
| Est. primary completion date | |
| Accepts healthy volunteers | |
| Gender | Both |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: - histologically confirmed extranodal NK/T cell lymphoma - primary site is skin or soft tissue Exclusion Criteria: - involvement of upper aerodigestive tract |
Observational Model: Cohort, Time Perspective: Retrospective
| Country | Name | City | State |
|---|---|---|---|
| Korea, Republic of | Samsung Medical Center | Seoul |
| Lead Sponsor | Collaborator |
|---|---|
| Samsung Medical Center |
Korea, Republic of,
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05426824 -
The Whole-course Management of Pegaspargase in ENKTL
|
N/A |